Anita Krishnarao, MD
Gastroenterology · Worcester, MANPI 1114365921
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $27,415 of the $40,332 with a category attached, or 68.0%. Madrigal Pharmaceuticals accounts for 79.9% of it on its own, with 7 other manufacturers making up the rest. 2025 is the largest year on record at $20,522, more than ten times the $91 reported in 2019. Among gastroenterology clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 60 payments — averaging $672.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Madrigal Pharmaceuticals$32K
- Daiichi Sankyo Inc.$8K
- Boston Scientific$177
- Veloxis Pharmaceuticals, Inc.$168
- Fujifilm Healthcare Americas Corporation$113
- Regeneron Healthcare Solutions, Inc.$71
- plus $71 from 2 others
Across 20 payments — averaging $2538.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Madrigal Pharmaceuticals$51K
What the payments were for
- Consulting fees$6,23015%
- Speaking & faculty fees$27,41568%
- Travel & lodging$4,43811%
- Food & beverage$2,2506%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Madrigal Pharmaceuticals | 36 | $32,225 |
| Daiichi Sankyo Inc. | 8 | $7,507 |
| Boston Scientific | 2 | $177 |
| Veloxis Pharmaceuticals, Inc. | 10 | $168 |
| Fujifilm Healthcare Americas Corporation | 1 | $113 |
| Regeneron Healthcare Solutions, Inc. | 1 | $71 |
| Novo Nordisk | 1 | $44 |
| AbbVie | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REZDIFFRA$31,390
- INJECTAFER$7,507
- WallFlex Duodenal$126
- FUJIFILM$113
How this compares
$40,332 in reported general payments places this provider in the 90th percentile of 579 gastroenterology providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XifaxanRifaximin | 40 | $136,791 |
| CreonLipase/Protease/Amylase | 13 | $31,807 |
| Ursodiol | 122 | $19,049 |
| Tacrolimus | 151 | $12,958 |
| Cyclosporine | 17 | $11,052 |
| Envarsus XrTacrolimus | 23 | $9,049 |
| SpsSodium Polystyrene Sulfon/Sorb | 12 | $6,885 |
| Sirolimus | 15 | $4,830 |
| Midodrine Hcl | 13 | $3,090 |
| Lactulose | 32 | $2,008 |
| Cyclosporine ModifiedCyclosporine, Modified | 18 | $1,960 |
| Mycophenolate Mofetil | 32 | $1,177 |
| Entecavir | 31 | $904 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 14 | $843 |
| Spironolactone | 43 | $842 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon | $27 | $31,80713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 579 gastroenterology providers in Massachusetts.
Other gastroenterology in Worcester
- Benjamin HyattWorcester$135K
- Neil MaryaWorcester$127K
- Curuchi AnandWorcester$117K
- Abbas RupawalaWorcester$74K
- Gustavo ChurrangoWorcester$51K
- Hiroyuki AiharaBoston$728K
- Jessica AllegrettiBoston$696K
- John LeungBoston$682K
- Ramnik XavierBoston$567K
- Adam CheifetzBoston$512K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.